TEZCANLI KAYMAZ, B. Et Al. 2015. Targeting STAT3 has therapeutic potential to regain nilotinib response in parental and resistant chronic myeloid leukemia cells. EACR-Sponsored 3rd Anticancer Agent Development Congress , (İzmir, Turkey), 182.

TEZCANLI KAYMAZ, B., SELVİ GÜNEL, N., BOZOK ÇETİNTAŞ, V., ADAN, A., BARAN, Y., GÜNDÜZ, C., ... KOSOVA CAN, B.(2015). Targeting STAT3 has therapeutic potential to regain nilotinib response in parental and resistant chronic myeloid leukemia cells . EACR-Sponsored 3rd Anticancer Agent Development Congress (pp.182). İzmir, Turkey

TEZCANLI KAYMAZ, BURÇİN Et Al. "Targeting STAT3 has therapeutic potential to regain nilotinib response in parental and resistant chronic myeloid leukemia cells," EACR-Sponsored 3rd Anticancer Agent Development Congress, İzmir, Turkey, 2015

TEZCANLI KAYMAZ, BURÇİN T. Et Al. "Targeting STAT3 has therapeutic potential to regain nilotinib response in parental and resistant chronic myeloid leukemia cells." EACR-Sponsored 3rd Anticancer Agent Development Congress , İzmir, Turkey, pp.182, 2015

TEZCANLI KAYMAZ, B. Et Al. (2015) . "Targeting STAT3 has therapeutic potential to regain nilotinib response in parental and resistant chronic myeloid leukemia cells." EACR-Sponsored 3rd Anticancer Agent Development Congress , İzmir, Turkey, p.182.

@conferencepaper{conferencepaper, author={BURÇİN TEZCANLI KAYMAZ Et Al. }, title={Targeting STAT3 has therapeutic potential to regain nilotinib response in parental and resistant chronic myeloid leukemia cells}, congress name={EACR-Sponsored 3rd Anticancer Agent Development Congress}, city={İzmir}, country={Turkey}, year={2015}, pages={182} }